Tesla is testing the $360 breakout zone – fail, and it could drop back to $313. If it succeeds, it targets $390+
2 extracted signals · 2 resolved · 0 still active
Wicked Stocks08 Sept 2025, 15:46 UTC
AI-generated source summary
The analysis for TSLA indicates a resistance area around $350. If the price closes above $360.21, a move towards $371.16 is anticipated, potentially leading to $390.98 within 2-3 weeks. Longer term, a methodical rally to $522.49 over the next 5-8 months is projected. A close below $313.97 would invalidate this bullish outlook. For NVDA, failure to sustain above the 2.5-year channel top suggests weakness. A settlement below $168.79 keeps $149.06 in view over the next 3-5 weeks. Closing above $168.79 could signal a bottom, with $158.71 as a downside target if $165.39 is broken.
AI-generated summary based on the source content.
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
2 eligible signals linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
Signals in this source
More Prediction Case Files from Wicked Stocks
Tesla Stock Price Analysis | Top $TSLA Levels To Watch for July 31st, 2026
#TSLA MAY BOUNCE FIRST... THEN FALL TO $227 #Tesla #daytrading
Tesla Stock Price Analysis | Top $TSLA Levels To Watch for July 30th, 2026
#TSLA BOUNCED FROM $300... BUT IS IT A TRAP? #Tesla #daytrading
Tesla Stock Price Analysis | Top $TSLA Levels To Watch for July 29th, 2026
#TSLA $300 TEST IS ALMOST HERE #Tesla #daytrading
Wicked Stocks
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

